Drug-induced Liver Injury in Patients with Underlying Liver Disease

Overview

Journal Clin Liver Dis (Hoboken)

Specialty Gastroenterology

Date 2024 Jun 11

PMID 38860131

Authors

Harshad C Devarbhavi

Cyriac Abby Philips

Affiliations

Soon will be listed here.

References

Jiang F, Yan H, Liang L, Du J, Jin S, Yang S . Incidence and risk factors of anti-tuberculosis drug induced liver injury (DILI): Large cohort study involving 4652 Chinese adult tuberculosis patients. Liver Int. 2021; 41(7):1565-1575. DOI: 10.1111/liv.14896. View

Kulkarni A, Hanchanale P, Prakash V, Kalal C, Sharma M, Kumar K . Tinospora Cordifolia (Giloy)-Induced Liver Injury During the COVID-19 Pandemic-Multicenter Nationwide Study From India. Hepatol Commun. 2022; 6(6):1289-1300. PMC: 9134809. DOI: 10.1002/hep4.1904. View

Chalasani N, Bonkovsky H, Fontana R, Lee W, Stolz A, Talwalkar J . Features and Outcomes of 899 Patients With Drug-Induced Liver Injury: The DILIN Prospective Study. Gastroenterology. 2015; 148(7):1340-52.e7. PMC: 4446235. DOI: 10.1053/j.gastro.2015.03.006. View

Lewis J, Stine J . Review article: prescribing medications in patients with cirrhosis - a practical guide. Aliment Pharmacol Ther. 2013; 37(12):1132-56. DOI: 10.1111/apt.12324. View

Edwards B, Mah H, Sabur N, Brode S . Hepatotoxicity and tuberculosis treatment outcomes in chronic liver disease. J Assoc Med Microbiol Infect Dis Can. 2023; 8(1):64-74. PMC: 10052910. DOI: 10.3138/jammi-2022-0029. View

Li H, Chen L, Zhang N, Li S, Zeng B, Pavesi M . Characteristics, Diagnosis and Prognosis of Acute-on-Chronic Liver Failure in Cirrhosis Associated to Hepatitis B. Sci Rep. 2016; 6:25487. PMC: 4857102. DOI: 10.1038/srep25487. View

Saraswat V, Singh S, Duseja A, Shukla A, Eapen C, Kumar D . Acute-on-chronic liver failure in India: The Indian National Association for Study of the Liver consortium experience. J Gastroenterol Hepatol. 2016; 31(10):1742-1749. DOI: 10.1111/jgh.13340. View

Zheng J, Guo M, Peng H, Cai X, Wu Y, Peng X . The role of hepatitis B infection in anti-tuberculosis drug-induced liver injury: a meta-analysis of cohort studies. Epidemiol Infect. 2020; 148:e290. PMC: 7770377. DOI: 10.1017/S0950268820002861. View

Racanelli V, Rehermann B . The liver as an immunological organ. Hepatology. 2006; 43(2 Suppl 1):S54-62. DOI: 10.1002/hep.21060. View

10.

Stephens C, Robles-Diaz M, Medina-Caliz I, Garcia-Cortes M, Ortega-Alonso A, Sanabria-Cabrera J . Comprehensive analysis and insights gained from long-term experience of the Spanish DILI Registry. J Hepatol. 2021; 75(1):86-97. DOI: 10.1016/j.jhep.2021.01.029. View

11.

Devarbhavi H, Aithal G, Treeprasertsuk S, Takikawa H, Mao Y, Shasthry S . Drug-induced liver injury: Asia Pacific Association of Study of Liver consensus guidelines. Hepatol Int. 2021; 15(2):258-282. DOI: 10.1007/s12072-021-10144-3. View

12.

Tarantino G, Conca P, Basile V, Gentile A, Capone D, Polichetti G . A prospective study of acute drug-induced liver injury in patients suffering from non-alcoholic fatty liver disease. Hepatol Res. 2007; 37(6):410-5. DOI: 10.1111/j.1872-034X.2007.00072.x. View

13.

Eaton J, Vuppalanchi R, Reddy R, Sathapathy S, Ali B, Kamath P . Liver Injury in Patients With Cholestatic Liver Disease Treated With Obeticholic Acid. Hepatology. 2019; 71(4):1511-1514. DOI: 10.1002/hep.31017. View

14.

Jing J, Wang R, Zhao X, Zhu Y, Niu M, Wang L . Association between the concurrence of pre-existing chronic liver disease and worse prognosis in patients with an herb- thunb. induced liver injury: a case-control study from a specialised liver disease center in China. BMJ Open. 2019; 9(1):e023567. PMC: 6340630. DOI: 10.1136/bmjopen-2018-023567. View

15.

Hwang S, Won S, Lee S . Nonalcoholic Fatty Liver Disease for the Incidence of Drug-Induced Liver Injury. Clin Gastroenterol Hepatol. 2021; 20(4):964-965. DOI: 10.1016/j.cgh.2021.06.023. View

16.

Regev A, Palmer M, Avigan M, Dimick-Santos L, Treem W, Marcinak J . Consensus: guidelines: best practices for detection, assessment and management of suspected acute drug-induced liver injury during clinical trials in patients with nonalcoholic steatohepatitis. Aliment Pharmacol Ther. 2019; 49(6):702-713. PMC: 6593464. DOI: 10.1111/apt.15153. View

17.

Shi Y, Yang Y, Hu Y, Wu W, Yang Q, Zheng M . Acute-on-chronic liver failure precipitated by hepatic injury is distinct from that precipitated by extrahepatic insults. Hepatology. 2015; 62(1):232-42. DOI: 10.1002/hep.27795. View

18.

Chirapongsathorn S, Sukeepaisarnjaroen W, Treeprasertsuk S, Chaiteerakij R, Surawongsin P, Hongthanakorn C . Characteristics of Drug-induced Liver Injury in Chronic Liver Disease: Results from the Thai Association for the Study of the Liver (THASL) DILI Registry. J Clin Transl Hepatol. 2022; 11(1):88-96. PMC: 9647102. DOI: 10.14218/JCTH.2021.00479. View

19.

Philips C, Paramaguru R, Augustine P, Rajesh S, Ahamed R, George T . A Single-Center Experience on Outcomes of Complementary and Alternative Medicine Use Among Patients With Cirrhosis. Hepatol Commun. 2019; 3(7):1001-1012. PMC: 6601323. DOI: 10.1002/hep4.1355. View

20.

Marie S, Frost K, Hau R, Martinez-Guerrero L, Izu J, Myers C . Predicting disruptions to drug pharmacokinetics and the risk of adverse drug reactions in non-alcoholic steatohepatitis patients. Acta Pharm Sin B. 2023; 13(1):1-28. PMC: 9939324. DOI: 10.1016/j.apsb.2022.08.018. View